Seikeikai New Tokyo Heart Clinic
About Seikeikai New Tokyo Heart Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Bayer
3
Clinical Trials at Seikeikai New Tokyo Heart Clinic
During the past decade, Seikeikai New Tokyo Heart Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
2017-12-12
2019-10-11
Completed
162
A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
2017-12-13
2019-11-28
Completed
164
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Seikeikai New Tokyo Heart Clinic"
#1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Seikeikai New Tokyo Heart Clinic
According to Clinical.Site data, the most researched conditions in "Seikeikai New Tokyo Heart Clinic" are
"Anemia" (2 trials), "Heart Failure" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials) and "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Seikeikai New Tokyo Heart Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Seikeikai New Tokyo Heart Clinic
Most popular intervention types in "Seikeikai New Tokyo Heart Clinic" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials) and "Linagliptin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Seikeikai New Tokyo Heart Clinic
The vast majority of trials in "Seikeikai New Tokyo Heart Clinic" are
8 trials for "All" genders.
Clinical Trials Status at Seikeikai New Tokyo Heart Clinic
Currently, there are NaN active trials in "Seikeikai New Tokyo Heart Clinic".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Seikeikai New Tokyo Heart Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Seikeikai New Tokyo Heart Clinic, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".